| Literature DB >> 21207208 |
Abstract
Patients with cardiovascular diseases commonly present with exercise intolerance, clinically manifest as shortness of breath and fatigue, and these symptoms have important prognostic implications. Cardiopulmonary exercise testing is a well-established method for evaluation of cardiopulmonary diseases. It provides an objective assessment of maximal aerobic capacity (peak VO(2)), estimates prognosis, and allows the physician to discriminate among many subtle and often overlapping etiologies. This review focuses on the evaluation of important exercise parameters, in addition to the peak VO(2), during cardiopulmonary exercise testing.Entities:
Mesh:
Year: 2011 PMID: 21207208 DOI: 10.1007/s11897-010-0042-4
Source DB: PubMed Journal: Curr Heart Fail Rep ISSN: 1546-9530